Reduction by arachidonic acid of prostaglandin i2-induced cyclic amp formation: Involvement of prostaglandins E2 and F2α
- 5 May 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (9) , 1815-1820
- https://doi.org/10.1016/0006-2952(93)90438-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - I. Biochemical Profile In VitroThrombosis and Haemostasis, 1989
- Ni‐mediated inhibition of human platelet adenylate cyclase by thrombinEuropean Journal of Biochemistry, 1984
- ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclaseNature, 1979
- Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometryProstaglandins, 1978
- Relation between the Inhibition of Aggregation and the Concentration of cAMP in Human and Rat PlateletsBritish Journal of Haematology, 1976
- Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acidInflammation Research, 1975
- Comparison between rat and rabbit anticyclic AMP antibodies—Specificity toward acyl derivatives of cyclic AMPAnalytical Biochemistry, 1973
- THE CONTROL OF PLATELET RESPONSIVENESS BY AGENTS THAT INFLUENCE CYCLIC AMP METABOLISMAnnals of the New York Academy of Sciences, 1972
- Preparation of Suspensions of Washed Platelets from HumansBritish Journal of Haematology, 1972
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962